Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'JOLY V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Abgrall, S; Charreau, I; Joly, V; Bloch, J; Reynes, J; Yeni, P
      Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    2. Auzary, C; Pinganaud, C; Launay, O; Joly, V; Cremieux, AC; Idatte, JM; Carbon, C
      Prosthetic valve endocarditis due to Coxiella burnetii: six cases.

      REVUE DE MEDECINE INTERNE
    3. Hance, AJ; Lemiale, V; Izopet, J; Lecossier, D; Joly, V; Massip, P; Mammano, F; Descamps, D; Brun-Vezinet, F; Clavel, F
      Changes in human immunodeficiency virus type 1 populations after treatmentinterruption in patients failing antiretroviral therapy

      JOURNAL OF VIROLOGY
    4. Chanetz, B; Pot, T; Bur, R; Joly, V; Larigaldie, S; Lefebvre, M; Marmignon, C; Mohamed, AK; Perraud, J; Pigache, D; Sagnier, P; Verant, JL; William, J
      High-enthalpy hypersonic project at ONERA

      AEROSPACE SCIENCE AND TECHNOLOGY
    5. Chemlal, K; Nochy, D; Kenouch, S; Joly, V; Carbon, C
      Dramatic improvement of renal dysfunction in a human immunodeficiency virus-infected woman treated with highly active antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    6. Joly, V; Moroni, M; Concia, E; Lazzarin, A; Hirschel, B; Jost, J; Chiodo, F; Bentwich, Z; Love, WC; Hawkins, DA; Wilkins, EGL; Gatell, AJ; Vetter, N; Greenwald, C; Freimuth, WW; De Cian, W
      Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: Evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    7. Joly, V; Yeni, P
      Non-nucleosidic reverse transcriptase inhibitors

      ANNALES DE MEDECINE INTERNE
    8. Grisch, F; Bouchardy, P; Joly, V; Marmignon, C; Koch, U; Gulhan, A
      Coherent anti-Stokes Raman scattering measurements and computational modeling of nonequilibrium flow

      AIAA JOURNAL
    9. Joly, V; Marmignon, C; Jacquet, P
      Vibrational relaxation of CO2(m, n(l), p) in a CO2-N-2 mixture. Part 2: Application to a one-dimensional problem

      AEROSPACE SCIENCE AND TECHNOLOGY
    10. Joly, V; Roblin, A
      Vibrational relaxation of CO2 (m, n(l), p) in a CO2-N-2 mixture. Part 1: Survey of available data

      AEROSPACE SCIENCE AND TECHNOLOGY
    11. Reynes, J; Raffi, F; Joly, V; Nevez, G; Dupont, B
      Itraconazole oral solution for treatment of fluconazole resistant oral/esophageal candidosis in HIV-infected patients: Results of a prospective multicenter study I. Clinical assessment

      JOURNAL DE MYCOLOGIE MEDICALE
    12. Been-Tiktak, AMM; Boucher, CAB; Brun-Vezinet, F; Joly, V; Mulder, JW; Jost, J; Cooper, DA; Moroni, M; Gatell, JM; Staszewski, S; Colebunders, R; Stewart, GJ; Hawkins, DA; Johnson, MA; Parkin, JM; Kennedy, DH; Hoy, JF; Borleffs, JCC
      Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    13. JOLY V; CARBON C
      EDITORIAL RESPONSE - UNFORTUNATE IN-VITRO SELECTION OF RESISTANT CANDIDA-ALBICANS WITH SEVERE CLINICAL CONSEQUENCES

      Clinical infectious diseases
    14. DARRASJOLY C; LUCET JC; LAISSY JP; CHOCHILLON C; CASALINO E; JOLY V; MATHERON S; BOUVET E
      INVASIVE ASPERGILLOSIS IN AIDS

      Pathologie et biologie
    15. Besson, C; Stelianides, S; Belmatoug, N; Silbermann-Hoffman, O; Couvelard, A; Joly, V; Carbon, C; Fantin, B
      Multifocal osteonecrosis after chemotherapy in a patient with breast cancer

      JOURNAL OF RHEUMATOLOGY
    16. Petit, C; Cheron, M; Joly, V; Rodrigues, JM; Bolard, J; Gaboriau, F
      In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating

      Journal of antimicrobial chemotherapy
    17. Broc, A; Joly, V; Lafon, JPJ; Marmignon, C
      Nonequilibrium radiative hypersonic flows: Aerospace applications

      ASTROPHYSICS AND SPACE SCIENCE
    18. JOLY V; BELMATOUG N; LEPERRE A; ROBERT J; JAULT F; CARBON C; YENI P
      PACEMAKER ENDOCARDITIS DUE TO CANDIDA-ALBICANS - CASE-REPORT AND REVIEW

      Clinical infectious diseases
    19. ABGRALL S; JOLY V; DERKINDEREN P; DECRE D; CARBON C; YENI P
      LACTOBACILLUS-CASEI INFECTION IN AN AIDS PATIENT

      European journal of clinical microbiology & infectious diseases
    20. JOLY V; MARMIGNON C
      EFFECT OF H2O VAPOR ON THE VIBRATIONAL-RELAXATION IN HYPERSONIC WIND TUNNELS

      Journal of thermophysics and heat transfer
    21. SEUXLEVIEIL ML; JOLY V; YENI P; CARBON C; BLANCHET F
      EVALUATION OF RENAL ACIDIFICATION IN HIV-INFECTED PATIENTS WITH HYPERGAMMAGLOBULINEMIA

      Nephron
    22. JOLY V
      INFECTION PROPHYLAXIS IN IMMUNOSUPPRESSED PATIENTS - PREVENTION OF TRANSFUSION-TRANSMITTED INFECTIONS

      Annales de medecine interne
    23. JOLY V; AUBRY P; NDAYIRAGIDE A; CARRIERE I; KAWA E; MLIKACABANNE N; ABOULKER JP; COULAUD JP; LAROUZE B; YENI P
      RANDOMIZED COMPARISON OF AMPHOTERICIN-B DEOXYCHOLATE DISSOLVED IN DEXTROSE OR INTRALIPID FOR THE TREATMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS

      Clinical infectious diseases
    24. DARRASJOLY C; CHEVRET S; WOLFF M; MATHERON S; LONGUET P; CASALINO E; JOLY V; CHOCHILLON C; BEDOS JP
      CRYPTOCOCCUS-NEOFORMANS INFECTION IN FRANCE - EPIDEMIOLOGIC FEATURES OF AND EARLY PROGNOSTIC PARAMETERS FOR 76 PATIENTS WHO WERE INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    25. JOLY V; BELMATOUG N; SIBERT A; CARBON C; YENI P
      SEPTIC THROMBOPHLEBITIS OF THE PORTAL-VEIN

      Clinical infectious diseases
    26. FANTIN B; JOLY V; ELBIM C; GOLMARD JL; GOUGEROTPOCIDALO MA; YENI P; CARBON C
      LYMPHOCYTE SUBSET COUNTS DURING THE COURSE OF COMMUNITY-ACQUIRED PNEUMONIA - EVOLUTION ACCORDING TO AGE, HUMAN-IMMUNODEFICIENCY-VIRUS STATUS, AND ETIOLOGIC MICROORGANISMS

      Clinical infectious diseases
    27. JOLY V; GEOFFRAY C; REYNES J; GOUJARD C; MECHALI D; MASLO C; RAFFI F; YENI P
      AMPHOTERICIN-B IN A LIPID EMULSION FOR THE TREATMENT OF CRYPTOCOCCAL MENINGITIS IN AIDS PATIENTS

      Journal of antimicrobial chemotherapy
    28. CHEMLAL K; SAINTJULIEN L; JOLY V; FARINOTTI R; SETA N; YENI P; CARBON C
      COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS

      Antimicrobial agents and chemotherapy
    29. JOLY V; KALFON P; POETE P; BODIN L; PUYBASSET L; CORIAT P; ROUBY JJ
      USE OF THE SAME HEAT AND MOISTURE EXCHANGER FOR 48 H IN INTENSIVE-CARE UNIT VENTILATED PATIENTS

      British Journal of Anaesthesia
    30. BEENTIKTAK AMM; JOLY V; SITBON G; COLLIN G; DEVOS M; DEGRAAF L; DEHAAN C; BOUCHER C; BRUMVEZINET F
      COMBINATION THERAPY WITH DELAVIRDINE MESYLATE AND AZT - VIROLOGY DATAFROM A EUROPEAN PHASE-II TRIAL

      Journal of acquired immune deficiency syndromes and human retrovirology
    31. JOLY V; YENI P
      NUCLEOTIDE ANALOGS FOR TREATMENT OF HIV-I NFECTION - NEW DATA

      La Presse medicale
    32. JOLY V
      VALUE OF ANIMAL-MODELS IN THE EVALUATION OF ANTIFUNGAL AGENTS

      Medecine et maladies infectieuses
    33. JOLY V
      VALUE OF ANIMAL-MODELS IN THE EVALUATION OF ANTIFUNGAL AGENTS

      Medecine et maladies infectieuses
    34. JOLY V
      BRITTANY DURING THE WAR, 1939-1945 - FREN CH - SAINCLIVIER,J

      Annales de Bretagne et des pays de l'Ouest
    35. JOLY V
      PREVENTION OF INVASIVE ASPERGILLOSIS VALU E OF CHEMOPROPHYLAXIS

      Pathologie et biologie
    36. CHAVANET P; JOLY V; RIGAUD D; BOLARD J; CARBON C; YENI P
      INFLUENCE OF DIET ON EXPERIMENTAL TOXICITY OF AMPHOTERICIN-B DEOXYCHOLATE

      Antimicrobial agents and chemotherapy
    37. JOLY V; FARINOTTI R; SAINTJULIEN L; CHERON M; CARBON C; YENI P
      IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID

      Antimicrobial agents and chemotherapy
    38. JOLY V; COQUEL F; MARMIGNON C; ARETZ W; METZ S; WILHELMI H
      NUMERICAL MODELING OF HEAT-TRANSFER AND RELAXATION IN NONEQUILIBRIUM AIR AT HYPERSONIC SPEEDS

      La Recherche aerospatiale
    39. JOLY V; SAINTJULIEN L; CARBON C; YENI P
      IN-VIVO ACTIVITY OF INTERFERON-GAMMA IN COMBINATION WITH AMPHOTERICIN-B IN THE TREATMENT OF EXPERIMENTAL CRYPTOCOCCOSIS

      The Journal of infectious diseases
    40. SABA J; MORLAT P; RAFFI F; HAZEBROUCQ V; JOLY V; LEPORT C; VILDE JL
      PYRIMETHAMINE PLUS AZITHROMYCIN FOR TREATMENT OF ACUTE TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS

      European journal of clinical microbiology & infectious diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 05:58:33